Évolution des symptômes neurologiques dans la maladie de Wilson après un an de traitement par dichlorhydrate de trientine : avantage aux femmes !
Aurélia Poujois(Fondation Ophtalmologique Adolphe de Rothschild), Carlot Kruse, Karl Heinz Weiss(Heidelberg University), Mickaël Alexandre Obadia(Fondation Ophtalmologique Adolphe de Rothschild)
Cited by 0
Related Papers
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study
|The Lancet. Gastroenterology & hepatology|2021|423
Cerebral venous thrombosis associated with COVID-19 infection: Causality or coincidence?
|Journal of Neuroradiology|2020|95
Direct Measurement of ATP7B Peptides Is Highly Effective in the Diagnosis of Wilson Disease
|Gastroenterology|2021|82
Anterior cerebral artery embolism during thrombectomy increases disability and mortality
|Journal of NeuroInterventional Surgery|2018|56